Author Correction: LARP4-mediated hypertranslation drives T cell dysfunction in tumors.

Saved in:
Bibliographic Details
Title: Author Correction: LARP4-mediated hypertranslation drives T cell dysfunction in tumors.
Authors: Liu Y; Institute for Immunology, Tsinghua University, Beijing, China.; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ni H; China National Center for Bioinformation, Beijing, China.; State Key Laboratory of RNA Innovation, Science and Engineering, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China., Li J; China National Center for Bioinformation, Beijing, China.; State Key Laboratory of RNA Innovation, Science and Engineering, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China., Yang J; China National Center for Bioinformation, Beijing, China.; State Key Laboratory of RNA Innovation, Science and Engineering, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China., Sekielyk I; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Karolinska Institutet, Stockholm, Sweden., Snow BE; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Zhang Z; Institute for Immunology, Tsinghua University, Beijing, China.; School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing, China.; Beijing Key Laboratory of Immunological Research of Allergy (LIRA), Tsinghua University, Beijing, China.; State Key Laboratory of Molecular Oncology, School of Basic Medical Sciences, Tsinghua University, Beijing, China., Zhang F; China National Center for Bioinformation, Beijing, China.; State Key Laboratory of RNA Innovation, Science and Engineering, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China., Paul MS; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Han J; Institute for Immunology, Tsinghua University, Beijing, China.; School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing, China.; Beijing Key Laboratory of Immunological Research of Allergy (LIRA), Tsinghua University, Beijing, China.; State Key Laboratory of Molecular Oncology, School of Basic Medical Sciences, Tsinghua University, Beijing, China., Kates M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Departments of Immunology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Liu S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Zhang Y; China National Center for Bioinformation, Beijing, China.; State Key Laboratory of RNA Innovation, Science and Engineering, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China., Huang Z; China National Center for Bioinformation, Beijing, China.; State Key Laboratory of RNA Innovation, Science and Engineering, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China., Xu Y; China National Center for Bioinformation, Beijing, China.; State Key Laboratory of RNA Innovation, Science and Engineering, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China., Saibil SD; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Departments of Immunology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Mak TW; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Departments of Immunology and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China.; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China., Han D; China National Center for Bioinformation, Beijing, China. handl@big.ac.cn.; State Key Laboratory of RNA Innovation, Science and Engineering, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China. handl@big.ac.cn.; College of Future Technology, Sino-Danish College, University of Chinese Academy of Sciences, Beijing, China. handl@big.ac.cn., Xu MM; Institute for Immunology, Tsinghua University, Beijing, China. michellexu@mail.tsinghua.edu.cn.; School of Basic Medical Sciences, Tsinghua Medicine, Tsinghua University, Beijing, China. michellexu@mail.tsinghua.edu.cn.; Beijing Key Laboratory of Immunological Research of Allergy (LIRA), Tsinghua University, Beijing, China. michellexu@mail.tsinghua.edu.cn.; State Key Laboratory of Molecular Oncology, School of Basic Medical Sciences, Tsinghua University, Beijing, China. michellexu@mail.tsinghua.edu.cn.
Source: Nature immunology [Nat Immunol] 2025 Sep; Vol. 26 (9), pp. 1626.
Publication Type: Published Erratum
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1529-2916
DOI:10.1038/s41590-025-02260-1